Treatment for metastatic melanoma is determined by the number of metastases, location, and size of metastases, prior treatment for melanoma, presence of a BRAF mutation, presence of extracranial metastases, and the patient’s current performance status [2]. This evidence concerns the gene BRAF and metastatic melanoma.